J.P. Morgan analyst David Adlington maintained a Buy rating on Fresenius SE & Co. KGaA (0OO9 – Research Report) on October 16 and ...

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With ...

Deutsche Bank analyst Falko Friedrichs maintained a Buy rating on Fresenius SE & Co. KGaA (0OO9 – Research Report) today and set a ...

Germany stocks were lower after the close on Monday, as losses in the Construction, Technology and Insurance sectors led ...

Germany's Fresenius said it was checking options to speed up the start of new production lines of medical equipment at a ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

While unionized workers claim there are unfair labor practices at certain clinics, Fresenius responds saying the National ...

Two major hurricanes have had medtech companies, including Baxter, B. Braun and Fresenius, scrambling to prevent a U.S. IV ...

Fresenius Medical Care's subsidiary, Xenios AG, has launched Xenios 2.0, a new system for extracorporeal life support (ECLS) ...

On October 4, 2024, Amgen filed a BPCIA complaint in the District Court for the Northern District of Illinois Eastern Division against Fresenius ...

Fresenius Kabi today launches its tocilizumab biosimilar Tyenne® referencing Actemra®** (tocilizumab) in Canada. Tyenne® is the first and only tocilizumab biosimilar currently available in Canada.